Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

24.33
Delayed Data
As of 4:00pm ET
 +1.17 / +5.05%
Today’s Change
16.75
Today|||52-Week Range
51.89
-26.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues77.5M57.4M11.6M14.4M
 
 
 
 
 
Depreciation And Amortization129.0K141.0K165.0K204.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses7.2M8.7M9.7M10.5M
 
 
 
 
 
Research And Development4.5M5.4M6.3M7.0M
 
 
 
 
 
Total Operating Expenses7.3M8.8M9.9M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income70.2M48.6M1.7M3.7M
 
 
 
 
 
Extraordinary Credit176.0K0.00--203.0K
 
 
 
Extraordinary Charge---17.0K-15.0K0.00
 
 
 
Interest Expense On Debt--2.0K2.0K2.0K
 
 
 
 
Other Expenses-2.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income70.5M48.8M2.0M4.2M
 
 
 
 
 
Income Taxes-28.5M-20.0M-428.0K-1.6M
 
 
 
 
 
Net Income42.0M28.8M2.4M5.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.6M18.7M18.7M18.7M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M19.3M19.3M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS$2.18$1.49$0.13$0.29
 
 
 
 
 
EPS Diluted$2.18$1.49$0.13$0.29